Corporate Information And Statement Of Ifrs Compliance [Abstract]
| Concept |
As at 2024-12-31 |
2024-01-01 to 2024-12-31 |
As at 2023-12-31 |
|---|---|---|---|
| Corporate information and statement of IFRS compliance [abstract] | |||
| Legal form of entity | — |
ASA
|
— |
| Address of entity's registered office | — |
Bjørnåsveien 5, 1596 Moss, Norway
|
— |
| Principal place of business | — |
Norway
|
— |
| Description of nature of entity's operations and principal activities | — |
The company is a research and development-
|
— |
| Name of ultimate parent of group | — |
Gentian Diagnostics ASA
|
— |
| Statement of IFRS compliance [text block] | — |
The company issues the consolidated financial statements in accordance with IFRS
|
— |
| Disclosure of reclassifications or changes in presentation [text block] | — |
Change in the Consolidated Statement of Profit or Loss and other comprehensive
|
— |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block] | — | — | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract] | |||
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items] | |||
| Current trade payables |
6 547
NOK
|
— |
3 706
NOK
|